Your browser doesn't support javascript.
loading
Weekly cisplatin (30-40 mg/m2) as radiosensitizer: Is it high or moderate emetic agent?
Karpe, A; Patil, V M; Joshi, A; Noronha, V; Gupta, S; Ramaswamy, A; Sahu, A; Doshi, V; Gupta, T; Rath, S; Banavali, S; Prabhash, K.
Afiliação
  • Karpe A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Patil VM; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Gupta S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Ramaswamy A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Sahu A; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Doshi V; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Gupta T; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Rath S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Banavali S; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India.
Indian J Cancer ; 53(3): 454-456, 2016.
Article em En | MEDLINE | ID: mdl-28244483
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Vômito / Cisplatino / Náusea / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radiossensibilizantes / Vômito / Cisplatino / Náusea / Antineoplásicos Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article